IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

a16z Capital Management, L.L.C.

Q3 2025 Holdings

Filed 2025-11-14 | 11 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Figma Inc(FIG)CLASS A COM STK316841105$842.7M16,246,12960.4%
Meta Platforms Inc(META)CL A30303M102$156.1M212,53111.2%
Revolution Medicines Inc(RVMD)COM76155X100$128.4M2,748,5239.2%
Omada Health Inc(OMDA)COM68170A108$102.0M4,614,5747.3%
Block Inc(XYZ)CL A852234103$73.5M1,016,6975.3%
Maze Therapeutics Inc(MAZE)COM578784100$44.1M1,702,2253.2%
Bioage Labs Inc(BIOA)COM09077V100$19.0M3,233,1701.4%
Nautilus Biotechnology Inc(NAUT)COM63909J108$14.9M17,653,9171.1%
Camp4 Therapeutics Corp(CAMP)COM13463J101$6.4M2,125,3390.5%
Erasca Inc(ERAS)COM29479A108$6.2M2,862,5000.4%
Ginkgo Bioworks Holdings Inc(DNA)CL A NEW37611X209$1.6M108,5680.1%